This HTML5 document contains 193 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
n11http://dx.doi.org/10.1007/
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n9http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
n7https://scigraph.springernature.com/pub.10.1007/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q52715248
rdf:type
wikibase:Item
schema:description
artículo científico publicado en 2018 teaduslik artikkel article scientifique научни чланак мақолаи илмӣ artykuł naukowy artikulong pang-agham 2018年學術文章 2018年学术文章 articol științific 2018年の論文 2018年学术文章 ৩০ এপ্রিল ২০১৮-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ artigo científico wetenschappelijk artikel 2018年學術文章 tudományos cikk სამეცნიერო სტატია 2018年学术文章 scientific article published on 30 April 2018 videnskabelig artikel tieteellinen artikkeli artigo científico artikel ilmiah مقالة علمية نشرت في 30 أبريل 2018 bilimsel makale vedecký článok scienca artikolo scientific article published on 30 April 2018 2018年學術文章 научна статия 2018年学术文章 article científic บทความทางวิทยาศาสตร์ vetenskaplig artikel artikull shkencor vědecký článek 2018年學術文章 наукова стаття, опублікована у квітні 2018 artículu científicu naučni članak επιστημονικό άρθρο 2018年学术文章 2018 nî lūn-bûn vitskapeleg artikkel artigo científico научни чланак articolo scientifico 2018年學術文章 wissenschaftlicher Artikel bài báo khoa học 2018年学术文章 article scientific vitenskapelig artikkel scientific article published on 30 April 2018 מאמר מדעי 2018년 논문 научная статья
p:P577
wds:Q52715248-B2D3E89A-F3CD-44F8-8595-D4DD1FEA1896
wdt:P577
2018-04-30T00:00:00Z
p:P2888
wds:Q52715248-47931123-197D-46F5-9F4B-D13EB5EB0130
wdt:P2888
n7:s00259-018-4015-2
p:P2860
wds:Q52715248-39801C1C-A2D9-4417-A085-57B450857F9A wds:Q52715248-487BD85B-3E95-410B-871F-E261BA420D60 wds:Q52715248-2E85ACD4-CA5A-480A-8A31-6D58608D497D wds:Q52715248-326A08F4-05EE-4ADB-9031-F290A3DAB4CC wds:Q52715248-394BA4C0-2189-49D3-A47E-C19B4218AB1D wds:Q52715248-1028E605-3894-4431-90D9-E07B3E9AE317 wds:Q52715248-04966869-45E5-4BDE-9506-1020BE8F8618 wds:Q52715248-068D3F98-BC57-4BE1-A65E-F1064E5F84F9 wds:Q52715248-08BE63D5-2245-4F51-8FA2-AF728C2A523D wds:Q52715248-9C6DEB67-7D5B-4C83-979A-989A49BA91AD wds:Q52715248-9C76A62C-1EAA-4118-8A11-75ADFFB96455 wds:Q52715248-8DB4796F-D492-4FB2-AF5A-597BA53D25AF wds:Q52715248-91275AB9-B5A1-4CD7-99D3-205917387BB5 wds:Q52715248-69098771-866F-4965-AA73-75E130C55B42 wds:Q52715248-73502985-85DD-47F1-9F75-7090CFAB4E94 wds:Q52715248-75790226-4A23-44C0-A0E1-EAD02494785E wds:Q52715248-4D900615-8F95-41CC-97CF-3F1FAA0C89DB wds:Q52715248-50EA0EC7-BE45-41F4-AA9C-F00B75D0370F wds:Q52715248-C1DCADAA-B76D-4245-8FC2-796433DA5F99 wds:Q52715248-D41AFB18-04D1-4C32-93AC-2E4C05BD1AED wds:Q52715248-AE5B11E2-F412-4419-A7C6-DD614A7E783D wds:Q52715248-BDACAF17-ECA6-49A9-A76E-4E505AFD6EBF wds:Q52715248-A73FBFD9-2241-46F7-9F26-18A390F346D0 wds:Q52715248-AA4410BC-EBE9-45EE-8058-738C8C566253 wds:Q52715248-A41C7984-8972-4A3B-8C84-6BD2670B85FA wds:Q52715248-FFCC1AF4-9555-47C6-B5E9-3F2D435C5F44 wds:Q52715248-F8404777-0DDC-45E7-8CCA-97D9329F8E39 wds:Q52715248-F93E643D-6473-4F44-9284-ADE9D8BB8584 wds:Q52715248-FD5CFE4E-CBF7-4136-B877-9C3225A7D7E0 wds:Q52715248-E7214D41-30FB-4E23-8D5A-D9DC06CEDD6E wds:Q52715248-EAF4998F-9B5F-4BBA-84BF-92B80A0F5268 wds:Q52715248-F362E54A-7001-4EA2-B6C4-7A95741A72C5 wds:Q52715248-DB3C3549-601E-4568-904C-2EBAF7A4139D wds:Q52715248-E190A948-BBCA-47FC-8CE9-1030513E92CF wds:Q52715248-E63AA1AE-EAD4-442B-90C7-6216462F3E7E wds:Q52715248-015AC220-4BEC-42B9-9508-A5593438E491
wdt:P2860
wd:Q36011283 wd:Q34132839 wd:Q34993336 wd:Q51819034 wd:Q33409575 wd:Q34277833 wd:Q35745251 wd:Q44435059 wd:Q27860910 wd:Q33705446 wd:Q44673208 wd:Q36621800 wd:Q38064831 wd:Q48099567 wd:Q30890927 wd:Q36879211 wd:Q48306398 wd:Q40405075 wd:Q28377308 wd:Q36500401 wd:Q40267133 wd:Q38031076 wd:Q34155598 wd:Q40034753 wd:Q35597936 wd:Q72333403 wd:Q34402294 wd:Q34521952 wd:Q27777800 wd:Q37036914 wd:Q43276389 wd:Q34131832 wd:Q55480234 wd:Q34377715 wd:Q48271471 wd:Q81284091
p:P2093
wds:Q52715248-C14DFA6B-B804-43C2-BE0E-3970D9D4AFF5
wdt:P2093
Adrian Merlo
rdfs:label
Prolonged survival in secondary glioblastoma following local injection of targeted alpha therapy with 213Bi-substance P analogue. Prolonged survival in secondary glioblastoma following local injection of targeted alpha therapy with 213Bi-substance P analogue.
skos:prefLabel
Prolonged survival in secondary glioblastoma following local injection of targeted alpha therapy with 213Bi-substance P analogue. Prolonged survival in secondary glioblastoma following local injection of targeted alpha therapy with 213Bi-substance P analogue.
schema:name
Prolonged survival in secondary glioblastoma following local injection of targeted alpha therapy with 213Bi-substance P analogue. Prolonged survival in secondary glioblastoma following local injection of targeted alpha therapy with 213Bi-substance P analogue.
p:P50
wds:Q52715248-EE7A829E-D67F-4DD8-8064-94289DFC2CD0 wds:Q52715248-AA72A818-21A2-4C24-80C3-08EE2749FF12 wds:Q52715248-ADE4F330-7067-45ED-A976-582859A67811 wds:Q52715248-D08438E9-94AC-43A2-B6FE-8F8358A49635 wds:Q52715248-5D6472D5-7EAC-4AAC-86C1-89403AE37F8A wds:Q52715248-6CAF7DEF-7786-488D-ACA9-8AF9562AE679 wds:Q52715248-91AA77E7-7023-4B0E-9D31-6BF3D74268AD wds:Q52715248-17D67234-E738-4CDD-8CA7-2D37419CE1CD wds:Q52715248-21A69AEB-2B58-4E72-A00D-6023E2BE8B51 wds:Q52715248-236EFC16-7165-4FC9-8AC3-48B87E6F91A3 wds:Q52715248-2D5666EE-CB35-42C8-B859-3DBCB36E7329
wdt:P50
wd:Q92607000 wd:Q114401016 wd:Q114401042 wd:Q114575185 wd:Q114575221 wd:Q57078358 wd:Q114401015 wd:Q114575220 wd:Q61946423 wd:Q93176146 wd:Q87061896
p:P1476
wds:Q52715248-96E63718-8411-4963-B7B0-6F1A281EFC3C
wdt:P1476
Prolonged survival in secondary glioblastoma following local injection of targeted alpha therapy with 213Bi-substance P analogue.
p:P304
wds:Q52715248-F66B20C8-C66F-4778-9082-5D339B7EBE71
wdt:P304
1636-1644
p:P31
wds:Q52715248-77BD470D-DF12-4DB8-AD49-D93F7A77E1F1
wdt:P31
wd:Q13442814
p:P921
wds:Q52715248-A4CA576B-ED87-4D9D-8E4D-EA0E724A2922 wds:Q52715248-0F2F04AA-2D70-41E1-A5B5-39F782C25F8A
wdt:P921
wd:Q411041 wd:Q282142
p:P698
wds:Q52715248-442B2B3C-0353-4CCB-A77F-23F8082F9AA0
wdtn:P698
n9:29713762
wdt:P698
29713762
p:P1433
wds:Q52715248-E3376567-A9A8-455F-BC97-3A5765E8EC12
wdt:P1433
wd:Q15708890
p:P433
wds:Q52715248-CA18DBF0-B540-4BCC-97C8-B53CBDEF923E
p:P478
wds:Q52715248-9D6DB88E-AE42-4F3D-A1AB-B1BF3338AADB
wdt:P433
9
wdt:P478
45
p:P356
wds:Q52715248-A27BEBB7-BDFF-4705-B6EA-512CBF466CE2
wdtn:P356
n11:S00259-018-4015-2
wdt:P356
10.1007/S00259-018-4015-2
p:P275
wds:Q52715248-0281d331-6e07-4987-9e18-c84c1fbf79a3
p:P6216
wds:Q52715248-63e3254c-2776-4f94-9327-9496899e41e4
wdt:P275
wd:Q20007257
wdt:P6216
wd:Q50423863
p:P932
wds:Q52715248-A07DCC65-85EF-4E0E-9926-C01F7E3ABA8A
wdt:P932
6061489